Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis To Work With Chinese Experts In Cancer Stem-Cell Research

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Sanofi-Aventis will expand its footprint in China by collaborating with Tianjin's Institute of Hematology and Blood Diseases Hospital (IHBDH) in the field of cancer stem cells, the French drug maker announced Sept. 14

You may also be interested in...



Sea Change In China’s Anti-Cancer Market Shares

China's hospitals are increasingly turning to alkaloid products such as paclitaxel and docetaxel to treat cancer while immunostimulant anti-cancer products see a decline in use, despite owning the largest market share

Sea Change In China’s Anti-Cancer Market Shares

China's hospitals are increasingly turning to alkaloid products such as paclitaxel and docetaxel to treat cancer while immunostimulant anti-cancer products see a decline in use, despite owning the largest market share

Sanofi-Aventis Expands R&D Presence In China

SHANGHAI - Sanofi-Aventis recently expanded its R&D presence in China to meet the rapid growth of clinical programs and broaden its activities from drug-target identification to late-stage clinical studies

UsernamePublicRestriction

Register

OM013133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel